Articles tagged with Spanish Influenza
Public Health Alerts provide concise, data-driven information on disease outbreaks and urgent health events. The new series, launched by NEJM Evidence and CIDRAP, offers expert-reviewed reports to support public health evidence-based care.
Researchers from University of Zurich and Basel decode historical specimen to understand how 1918-1920 influenza pandemic evolved in Europe. The Swiss genome reveals three key adaptations that made the virus more resistant to human immunity and more infectious.
The American College of Chest Physicians (CHEST) has launched a critical care APP education and certification program, covering 11 topic areas including patient-centered care and pharmacology. The CCAPP Certification Exam is now available, with an August 5 deadline to apply for the 2025 exam.
The American College of Chest Physicians' CHEST Critical Care and CHEST Pulmonary journals have been indexed in Elsevier's Scopus database. This achievement is a testament to the high-quality research published in these journals, which provide open access content in pulmonary and critical care medicine.
Researchers found that individuals with previous environmental, social, and nutritional stressors were more likely to die from the flu. This contradicts the widespread belief that healthy young adults were disproportionately affected. The study analyzed skeletal remains of 369 victims and identified lesions as indicators of frailty.
A historical analysis of Bern Maternity Hospital data showed a notable surge in low birth weight and stillbirth rates coinciding with the 1918 'Spanish flu' pandemic. Researchers found that mothers exposed to the pandemic had a higher risk of stillbirth, highlighting the potential impact of pandemics on infant health.
A study by Max Planck Researcher Jonas Schöley and colleagues found that life expectancy continued to decline globally in 2021, with differences between Eastern and Western Europe widening. However, vaccination efforts helped mitigate mortality shocks in some countries, particularly those with robust healthcare systems.
The study found that the spread of Spanish flu differed depending on the region, with a decrease in infection numbers associated with public health measures. Delayed action at the start of the second wave was fatal, contributing to its severity and duration. The researchers compared historical data from 1918 and 2020 and found parallel...
The Brazilian Navy faced its worst enemy in WWI - the Spanish flu, resulting in over 100 soldier deaths. The research sheds light on the factors contributing to this tragic event, including weakened respiratory systems and lack of immunity.
A new study from the Norwegian Institute of Public Health found significant differences in mortality rates between urban and isolated rural communities during the 1918 Spanish flu pandemic. Mortality rates were much higher in isolated communities, with up to 90-100% of adults over 30 years dying from the virus.
Researchers found that the 2009 H1N1 influenza vaccine may also protect against the lethal 1918 Spanish influenza virus, alleviating bioterrorism concerns. The study demonstrates cross-protection, showing that people vaccinated against H1N1 may also be protected against 1918.
Researchers found that transfusions with blood products from recovered Spanish flu patients may reduce mortality and improve symptoms for hospitalized patients. The study suggests similar transfusions could be useful in treating victims of a bird flu pandemic, especially given the problems with existing vaccines and treatments.
Two research papers, 'Characterization of the 1918 influenza virus polymerase genes' and 'Characterization of the reconstructed 1918 Spanish influenza pandemic virus', win Lancet's Paper of The Year 2005. The studies provide crucial insights into the 1918 pandemic, which is believed to have killed up to 50 million people.
A team of researchers has identified key genes responsible for the Spanish flu's extreme virulence, which could lead to the development of effective antivirals and vaccines. The study also suggests that certain FDA-approved flu medications may be effective against future strains of the virus.
Researchers identified a hybrid gene in the 1918 flu virus that was produced from parts of two other influenza viruses through a process called recombination. This discovery suggests that the outbreak was triggered by the recombination, which increased the virus's virulence.